1. Home
  2. SUPV vs SLDB Comparison

SUPV vs SLDB Comparison

Compare SUPV & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grupo Supervielle S.A. each Representing five Class B shares

SUPV

Grupo Supervielle S.A. each Representing five Class B shares

N/A

Current Price

$5.68

Market Cap

703.9M

Sector

Finance

ML Signal

N/A

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

N/A

Current Price

$7.02

Market Cap

623.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SUPV
SLDB
Founded
1887
2013
Country
Argentina
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
703.9M
623.0M
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
SUPV
SLDB
Price
$5.68
$7.02
Analyst Decision
Hold
Strong Buy
Analyst Count
5
15
Target Price
$11.80
★ $18.71
AVG Volume (30 Days)
548.2K
★ 1.4M
Earning Date
11-16-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 34.97
EPS
★ N/A
N/A
Revenue
N/A
★ $8,094,000.00
Revenue This Year
$34.17
N/A
Revenue Next Year
$20.05
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$5.45
$4.16
52 Week High
$12.63
$11.45

Technical Indicators

Market Signals
Indicator
SUPV
SLDB
Relative Strength Index (RSI) 31.19 54.36
Support Level $5.45 $6.25
Resistance Level $10.24 $7.42
Average True Range (ATR) 0.35 0.49
MACD -0.05 0.21
Stochastic Oscillator 14.40 63.12

Price Performance

Historical Comparison
SUPV
SLDB

About SUPV Grupo Supervielle S.A. each Representing five Class B shares

Grupo Supervielle SA a diversified financial services group in Argentina. It offers a broad range of financial products and services including lending, savings and investments, insurance, payments and cash management services, car loans, and asset management, positioning itself as a one-stop destination for financial needs. It operates exclusively in Argentina, through the Bank, which serves as its main banking subsidiary, delivering a comprehensive suite of financial services to retail, SMEs and corporate customers. Its segments include Personal & Business Banking; Corporate Banking; Bank Treasury; Insurance; and Asset Management and Other Services (which includes IOL invertironline). The majority of the revenue is derived from Personal & Business Banking segment.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: